Technical Analysis for EPGNY - Epigenomics Ag

Grade Last Price % Change Price Change
grade F 5.9717 0.40% 0.0237
EPGNY closed up 0.4 percent on Wednesday, November 13, 2019, on 53 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical EPGNY trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 0.40%
Narrow Range Bar Range Contraction 0.40%
Lower Bollinger Band Walk Weakness 0.40%

Older signals for EPGNY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Epigenomics is a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation biomarker technology. The company develops and commercializes diagnostic products across multiple cancer indications with high medical need. Epigenomics' lead product, Epi proColon, is a blood-based screening test for the detection of colorectal cancer. Epi proColon has received approval from the U.S. Food and Drug Administration (FDA) and is currently marketed in the United States, Europe, and China and selected other countries. Epigenomics’ second product, Epi proLung, is in development as a blood-based test for lung cancer detection. For more information, visit www.epigenomics.com.
Medicine Biotechnology RTT Branches Of Biology Cancer Clinical Medicine Cancers Colorectal Cancer Diagnostic Products Biomarkers Molecular Diagnostics Lung Cancer Medical Genetics Cancer Detection U.S. Food And Drug Administration Epigenomics Ag
Is EPGNY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 41.74
52 Week Low 5.35
Average Volume 759
200-Day Moving Average 0.0
50-Day Moving Average 15.9444
20-Day Moving Average 9.6045
10-Day Moving Average 8.218
Average True Range 1.0708
ADX 23.98
+DI 30.3402
-DI 55.5478
Chandelier Exit (Long, 3 ATRs ) 9.6376
Chandelier Exit (Short, 3 ATRs ) 8.5624
Upper Bollinger Band 13.3189
Lower Bollinger Band 5.8901
Percent B (%b) 0.01
BandWidth 77.347077
MACD Line -2.5489
MACD Signal Line -2.5869
MACD Histogram 0.038
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.9043
Resistance 3 (R3) 6.8006 6.3862 6.7488
Resistance 2 (R2) 6.3862 6.1487 6.4380 6.6970
Resistance 1 (R1) 6.1789 6.0020 6.2826 6.2826 6.6452
Pivot Point 5.7645 5.7645 5.8163 5.8163 5.7645
Support 1 (S1) 5.5572 5.5270 5.6609 5.6609 5.2982
Support 2 (S2) 5.1428 5.3803 5.1946 5.2464
Support 3 (S3) 4.9355 5.1428 5.1946
Support 4 (S4) 5.0392